Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Characterization of the Human Hematopoietic Niche During Ontogeny.

View through CrossRef
Abstract Abstract 3626 Poster Board III-562 Studies thus far have shown that there are at least two anatomically and physiologically distinct hematopoietic niches within the bone marrow (BM); the osteoblastic and the vascular. The former is thought to provide the appropriate support for quiescent hematopoietic stem cells (HSC), while the latter allows/induces expansion of the HSC pool. However, it is not entirely known which subpopulations of HSC interact with each niche, and what physiological role each niche type plays in the regulation of stem cell hierarchy and function. We hypothesized that the developmental process whereby the fetal marrow acquires the ability to support hematopoiesis can be used as a model for understanding both the interactions that occur between HSC and the cells comprising the marrow niches, and the role of these niche elements in the initiation/maintenance of hematopoiesis. To this end, human fetal bones between 10- 22 weeks of gestation (gw) were analyzed by flow cytometry and confocal microscopy to identify and characterize stromal/vascular/osteoblastic and hematopoietic elements. Since the development of the vascular bed has been reported to occur in humans between 9-10.5gw, we started the analysis of the human fetal bones at this time point (n=3). CD44 was the only marker widely expressed at this time point, suggesting that these bone rudiments were in an earlier (cartilaginous) stage of development. At 12gw (n=5), 47±4% of the cells isolated from the long bones were CD34+, but less than 1% of these cells were positive for CD45. Further characterization of the CD45−CD34+ population showed that 74±5.4% of these cells were CD106+; 65±7.2% were CD102+; 10±0.5% were CD31+; and 6.7±2.1 % KDR+. These data suggest that prior to the onset of hematopoiesis, a significant percentage of the cells in the BM are part of the vascular niche, and have an endothelial cell phenotype. Furthermore, the existence of a population of cells with a CD34+CD31+KDR+CD45− phenotype may indicate that, during this stage of development, a hemangioblast-like cell exists in the emergent BM. In addition, the existence of a large mesenchymal/stromal cell population was also found, with 21±2.9% of the cells expressing Stro-1+. CD44 was still widely expressed (55±7.8%) at this time point. Of particular note is the discovery of a cell population in which CD44+ cells co-expressed CD34 in the absence of CD45 (8±1.8%), and another in which CD34+ cells were co-expressing Stro-1 (9±1 %), suggesting the possibility that a common ancestor may exist for these cells. At 16gw (n=6) the overall percentage of CD34+ cells decreased to 15±3.1%, and the majority (72±7%) of the cells harvested from the long bones expressed CD45, showing the change to a predominantly hematopoietic marrow. Furthermore, 12±4.2% of the cells had a CD45+CD34+ phenotype consistent with that of HSC. At this time point, only 2.38±1% of the cells were CD34+CD106+; 3.5±1.5% were CD34+CD102+; and 1.34±0.8% were CD34+CD31+. In addition, the CD44+CD45- population decreased to only 20±1.2%. At 22gw (n=6), a similar flow cytometric profile was found except that the CD45+CD34+ population had decreased to 6±1.3%. Since phenotypic analysis showed a decrease in the percentage of BM stromal cell precursors from 12 to 22gw, we performed CFU-F assays and found that the frequency of CFU-F in 12gw BM was 0.34-0.45%, the highest found at any time point. At 16gw, the frequency of CFU-F was 0.23-0.25%, and at 22gw, it had decreased to 0.1-0.16%. Nevertheless, even this low level at 22gw was still higher than that of adult BM (0.001-0.02%). Thus, the results from CFU-F assays correlate well with the flow cytometry/confocal microscopy data showing that there is a decrease in mesenchymal/stromal cell precursor frequency/potential as the BM niches mature. To investigate the ability of the stromal layers of different gestational ages to interact with/retain HSC, adhesion assays (n=3) were performed with cord blood (CB) and adult BM-derived CD34+ cells. These studies showed that CB CD34+ cells adhered at similar levels to all of the fetal stromal layers, while adult BM-derived CD34+ cells only adhered efficiently to the 22gw stromal layers. Further studies addressing the cellular interactions that occur within each of the niches at the phenotypic, functional, and transcriptional levels are currently underway. Disclosures: No relevant conflicts of interest to declare.
Title: Characterization of the Human Hematopoietic Niche During Ontogeny.
Description:
Abstract Abstract 3626 Poster Board III-562 Studies thus far have shown that there are at least two anatomically and physiologically distinct hematopoietic niches within the bone marrow (BM); the osteoblastic and the vascular.
The former is thought to provide the appropriate support for quiescent hematopoietic stem cells (HSC), while the latter allows/induces expansion of the HSC pool.
However, it is not entirely known which subpopulations of HSC interact with each niche, and what physiological role each niche type plays in the regulation of stem cell hierarchy and function.
We hypothesized that the developmental process whereby the fetal marrow acquires the ability to support hematopoiesis can be used as a model for understanding both the interactions that occur between HSC and the cells comprising the marrow niches, and the role of these niche elements in the initiation/maintenance of hematopoiesis.
To this end, human fetal bones between 10- 22 weeks of gestation (gw) were analyzed by flow cytometry and confocal microscopy to identify and characterize stromal/vascular/osteoblastic and hematopoietic elements.
Since the development of the vascular bed has been reported to occur in humans between 9-10.
5gw, we started the analysis of the human fetal bones at this time point (n=3).
CD44 was the only marker widely expressed at this time point, suggesting that these bone rudiments were in an earlier (cartilaginous) stage of development.
At 12gw (n=5), 47±4% of the cells isolated from the long bones were CD34+, but less than 1% of these cells were positive for CD45.
Further characterization of the CD45−CD34+ population showed that 74±5.
4% of these cells were CD106+; 65±7.
2% were CD102+; 10±0.
5% were CD31+; and 6.
7±2.
1 % KDR+.
These data suggest that prior to the onset of hematopoiesis, a significant percentage of the cells in the BM are part of the vascular niche, and have an endothelial cell phenotype.
Furthermore, the existence of a population of cells with a CD34+CD31+KDR+CD45− phenotype may indicate that, during this stage of development, a hemangioblast-like cell exists in the emergent BM.
In addition, the existence of a large mesenchymal/stromal cell population was also found, with 21±2.
9% of the cells expressing Stro-1+.
CD44 was still widely expressed (55±7.
8%) at this time point.
Of particular note is the discovery of a cell population in which CD44+ cells co-expressed CD34 in the absence of CD45 (8±1.
8%), and another in which CD34+ cells were co-expressing Stro-1 (9±1 %), suggesting the possibility that a common ancestor may exist for these cells.
At 16gw (n=6) the overall percentage of CD34+ cells decreased to 15±3.
1%, and the majority (72±7%) of the cells harvested from the long bones expressed CD45, showing the change to a predominantly hematopoietic marrow.
Furthermore, 12±4.
2% of the cells had a CD45+CD34+ phenotype consistent with that of HSC.
At this time point, only 2.
38±1% of the cells were CD34+CD106+; 3.
5±1.
5% were CD34+CD102+; and 1.
34±0.
8% were CD34+CD31+.
In addition, the CD44+CD45- population decreased to only 20±1.
2%.
At 22gw (n=6), a similar flow cytometric profile was found except that the CD45+CD34+ population had decreased to 6±1.
3%.
Since phenotypic analysis showed a decrease in the percentage of BM stromal cell precursors from 12 to 22gw, we performed CFU-F assays and found that the frequency of CFU-F in 12gw BM was 0.
34-0.
45%, the highest found at any time point.
At 16gw, the frequency of CFU-F was 0.
23-0.
25%, and at 22gw, it had decreased to 0.
1-0.
16%.
Nevertheless, even this low level at 22gw was still higher than that of adult BM (0.
001-0.
02%).
Thus, the results from CFU-F assays correlate well with the flow cytometry/confocal microscopy data showing that there is a decrease in mesenchymal/stromal cell precursor frequency/potential as the BM niches mature.
To investigate the ability of the stromal layers of different gestational ages to interact with/retain HSC, adhesion assays (n=3) were performed with cord blood (CB) and adult BM-derived CD34+ cells.
These studies showed that CB CD34+ cells adhered at similar levels to all of the fetal stromal layers, while adult BM-derived CD34+ cells only adhered efficiently to the 22gw stromal layers.
Further studies addressing the cellular interactions that occur within each of the niches at the phenotypic, functional, and transcriptional levels are currently underway.
Disclosures: No relevant conflicts of interest to declare.

Related Results

Origin and Characterization of CD166+ Cells During Human Marrow Ontogeny
Origin and Characterization of CD166+ Cells During Human Marrow Ontogeny
Abstract Abstract 1252 The development of hematopoiesis during embryonic and fetal life has served as a valuable model for characterizing putative HSC...
UM171 Regulates the Hematopoietic Differentiation of Human Acquired Aplastic Anemia-Derived Induced Pluripotent Stem Cells
UM171 Regulates the Hematopoietic Differentiation of Human Acquired Aplastic Anemia-Derived Induced Pluripotent Stem Cells
Aplastic anemia (AA) is characterized by a hypoplastic bone marrow associated with low peripheral blood counts. In acquired cases, the immune system promotes hematopoietic stem and...
Targeting EBF1-ITGB8 Axis in MPN Bone Marrow Niche
Targeting EBF1-ITGB8 Axis in MPN Bone Marrow Niche
Hematopoiesis occurs in a complex bone marrow (BM) microenvironment that includes mesenchymal stromal cells (MSCs). The integrity and fitness of hematopoietic stem cell (HSC) pool ...
Self-Renewal and BM Niche Occupancy Defects In NHEJ Deficient HSCs.
Self-Renewal and BM Niche Occupancy Defects In NHEJ Deficient HSCs.
Abstract Abstract 1455 Maintenance of hematopoietic stem cells (HSC) requires proper interaction between HSC and the bone marrow niche. DNA repair pro...
Hematopoietic aging: Cellular, molecular, and related mechanisms
Hematopoietic aging: Cellular, molecular, and related mechanisms
Abstract Aging is accompanied by significant inhibition of hematopoietic and immune system function and disruption of bone marrow structure. Aging-related alter...
The Role of Gja1 Gap Junctions in the Bone Marrow Niche.
The Role of Gja1 Gap Junctions in the Bone Marrow Niche.
Abstract The interplay between the stroma and hematopoietic progenitors within the bone marrow niche is critical for the homeostatic regulation of both mesenchymal a...

Back to Top